weekly weight loss on tirzepatide A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% ✓ Semaglutide: 13.7% weight loss But weight loss isn't the We now are offering Tirzepatide

Movement : your body regularly

Regeneron also joined the list of companies mounting a challenge to Lilly this week

Despite widespread use, this population is underrepresented in clinical trials, creating a knowledge gap around long-term safety and optimal use

Individuals facing plateaus with lifestyle changes For those who have struggled with diet and exercise alone, GLP-1 drugs can offer an additional boost

A: The standard and FDA-approved dosing protocol for injectable semaglutide is once a week

When properly stored in a refrigerator at the advised temperature and assuming the cold chain remains intact, semaglutide remains effective until the expiration date provided by the manufacturer , which typically ranges from several months to a year after purchase